Records containing: Hepatocellular Carcinoma (HCC)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-26A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
-
CLINICAL_TRIALS study record update · 2025-11-20An Open-label, Multicenter Phase 2 Clinical Study on the Efficacy and Safety of BB102 in Patients With Advanced or Unresectable FGF19-overexpressing Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2025-11-18A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2025-11-18AI-human Collaborative Diagnosis of Liver Tumors Using CE-CT
-
CLINICAL_TRIALS study record update · 2025-11-17Streamlined Resin Y90 Radiation Segmentectomy for Small HCC: One&Done Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-12Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination With Dostarlimab in Pediatric and Young Adult Participants With Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)
-
CLINICAL_TRIALS study record update · 2025-10-21A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
-
CLINICAL_TRIALS study record update · 2025-10-14A Randomized, Open-label, Multicenter Phase 3 Study to Compare the Efficacy and Safety of BGB-A317 Versus Sorafenib as First-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2025-10-10Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study
-
CLINICAL_TRIALS study record update · 2025-10-08Abbreviated MRI for HCC Screening in Cirrhotic Patients (FAST-MRI Study)
-
CLINICAL_TRIALS study record update · 2025-09-25Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab: a Single Arm Trial.
-
CLINICAL_TRIALS study record update · 2025-09-23Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
-
CLINICAL_TRIALS study record update · 2025-09-22Adjuvant Radiotherapy Combined With Sintilimab Versus Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma With Narrow Margins and High-Risk Features Following Resection: A Multi-center Phase III Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-09-19A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2025-09-19Phase Ib Exploratory Study on the Combination of JS014 and Toripalimab in Combination With Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.
-
CLINICAL_TRIALS study record update · 2025-09-19Ct Volume Measurement of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) or Microwave Ablation (MWA)
-
CLINICAL_TRIALS study record update · 2025-09-12Development of a Computer-Aided Diagnosis System for Hepatocellular Carcinoma Microvascular Invasion Based on Preoperative Image Analysis
-
CLINICAL_TRIALS study record update · 2025-09-05A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
-
CLINICAL_TRIALS study record update · 2025-09-05AI-Driven Multitask Model for Guiding Treatment Decision-Making in Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2025-09-04A Prospective, Single-arm, Phase Ⅱ Study of Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Resectable Centrally-located Hepatocellular Carcinoma in BCLC Stage B
-
CLINICAL_TRIALS study record update · 2025-09-03A Phase II, Single-arm, Multi-center Trial of Cabozantinib for Progressive Hepatocellular Carcinoma (HCC) Post-first-line Immuno-oncologic Combination Therapy (CAPIO Study)
-
CLINICAL_TRIALS study record update · 2025-09-03A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of TPST-1120 in Combination With Atezolizumab Plus Bevacizumab Compared With Placebo Plus Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Not Previously Treated With Systemic Therapy
-
CLINICAL_TRIALS study record update · 2025-09-02A Phase II Single-Arm Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Lenvatinib and TACE for Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2025-09-02Polyene Phosphatidylcholine Injection for the Treatment of Perioperative Liver Injury With Laparoscopic Hemihepatectomy in Hepatocellular Carcinoma: a Multicenter Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2025-08-27A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (SIRT) Therapy and Hepatic Arterial Infusion Chemotherapy (HAIC) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma